Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Paliperidone Palmitate Long-Acting Injection Market Size(US$)
CAGR 2025-2031
6.3%
Market Size,2031
USD 6,283
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 4,355 million
Market Forecast in 2031(Value)
US$ 6,283 million
CAGR
6.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Paliperidone palmitate long-acting injection is a sustained-release antipsychotic injection, the main ingredient of which is paliperidone palmitate, a long-acting esterified form of paliperidone. The preparation is administered by intramuscular injection and can gradually hydrolyze and release active drugs in the body to achieve a sustained therapeutic effect. It is usually injected once a month for the treatment of schizophrenia and related mental disorders, which helps to improve patient compliance, reduce the risk of relapse and improve treatment stability.
The North America Paliperidone Palmitate Long-Acting Injection market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Paliperidone Palmitate Long-Acting Injection include Janssen Pharmaceuticals, Teva Pharmaceutical, Viatris, Sun Pharmaceutical, Cipla, Hikma Pharmaceuticals, Qilu Pharmaceutical, Hansoh Pharmaceuticak Group, Luye Pharma Group, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Paliperidone Palmitate Long-Acting Injection market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Paliperidone Palmitate Long-Acting Injection market competitiveness, regional economic performance, and supply chain configurations.
Market Segmentation
By Company
- Janssen Pharmaceuticals
- Teva Pharmaceutical
- Viatris
- Sun Pharmaceutical
- Cipla
- Hikma Pharmaceuticals
- Qilu Pharmaceutical
- Hansoh Pharmaceuticak Group
- Luye Pharma Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Monthly Dosage Form
- Quarterly Dosage Form
Segment by Application
- General Hospital
- Specialized Hospital
- Others
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Paliperidone Palmitate Long-Acting Injection market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Quarterly Dosage Form in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Specialized Hospital in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Paliperidone Palmitate Long-Acting Injection Product Scope
1.2 Paliperidone Palmitate Long-Acting Injection by Type
1.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Type (2020 & 2024 & 2031)
1.2.2 Monthly Dosage Form
1.2.3 Quarterly Dosage Form
1.3 Paliperidone Palmitate Long-Acting Injection by Application
1.3.1 Global Paliperidone Palmitate Long-Acting Injection Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 General Hospital
1.3.3 Specialized Hospital
1.3.4 Others
1.4 Global Paliperidone Palmitate Long-Acting Injection Market Estimates and Forecasts (2020-2031)
1.4.1 Global Paliperidone Palmitate Long-Acting Injection Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Paliperidone Palmitate Long-Acting Injection Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Paliperidone Palmitate Long-Acting Injection Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Paliperidone Palmitate Long-Acting Injection Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Paliperidone Palmitate Long-Acting Injection Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Region (2020-2025)
2.2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Region (2020-2025)
2.3 Global Paliperidone Palmitate Long-Acting Injection Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Paliperidone Palmitate Long-Acting Injection Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Paliperidone Palmitate Long-Acting Injection Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Paliperidone Palmitate Long-Acting Injection Market Size and Prospective (2020-2031)
2.4.2 Europe Paliperidone Palmitate Long-Acting Injection Market Size and Prospective (2020-2031)
2.4.3 China Paliperidone Palmitate Long-Acting Injection Market Size and Prospective (2020-2031)
2.4.4 Japan Paliperidone Palmitate Long-Acting Injection Market Size and Prospective (2020-2031)
2.4.5 India Paliperidone Palmitate Long-Acting Injection Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Paliperidone Palmitate Long-Acting Injection Historic Market Review by Type (2020-2025)
3.1.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Type (2020-2025)
3.1.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Type (2020-2025)
3.1.3 Global Paliperidone Palmitate Long-Acting Injection Price by Type (2020-2025)
3.2 Global Paliperidone Palmitate Long-Acting Injection Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Forecast by Type (2026-2031)
3.2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue Forecast by Type (2026-2031)
3.2.3 Global Paliperidone Palmitate Long-Acting Injection Price Forecast by Type (2026-2031)
3.3 Different Types Paliperidone Palmitate Long-Acting Injection Representative Players
4 Global Market Size by Application
4.1 Global Paliperidone Palmitate Long-Acting Injection Historic Market Review by Application (2020-2025)
4.1.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Application (2020-2025)
4.1.2 Global Paliperidone Palmitate Long-Acting Injection Revenue by Application (2020-2025)
4.1.3 Global Paliperidone Palmitate Long-Acting Injection Price by Application (2020-2025)
4.2 Global Paliperidone Palmitate Long-Acting Injection Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Paliperidone Palmitate Long-Acting Injection Sales Forecast by Application (2026-2031)
4.2.2 Global Paliperidone Palmitate Long-Acting Injection Revenue Forecast by Application (2026-2031)
4.2.3 Global Paliperidone Palmitate Long-Acting Injection Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Paliperidone Palmitate Long-Acting Injection Application
5 Competition Landscape by Players
5.1 Global Paliperidone Palmitate Long-Acting Injection Sales by Players (2020-2025)
5.2 Global Top Paliperidone Palmitate Long-Acting Injection Players by Revenue (2020-2025)
5.3 Global Paliperidone Palmitate Long-Acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone Palmitate Long-Acting Injection as of 2024)
5.4 Global Paliperidone Palmitate Long-Acting Injection Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Product Type & Application
5.7 Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Paliperidone Palmitate Long-Acting Injection Sales by Company
6.1.1.1 North America Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025)
6.1.1.2 North America Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025)
6.1.2 North America Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Type (2020-2025)
6.1.3 North America Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Application (2020-2025)
6.1.4 North America Paliperidone Palmitate Long-Acting Injection Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Paliperidone Palmitate Long-Acting Injection Sales by Company
6.2.1.1 Europe Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025)
6.2.1.2 Europe Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025)
6.2.2 Europe Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Type (2020-2025)
6.2.3 Europe Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Application (2020-2025)
6.2.4 Europe Paliperidone Palmitate Long-Acting Injection Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Paliperidone Palmitate Long-Acting Injection Sales by Company
6.3.1.1 China Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025)
6.3.1.2 China Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025)
6.3.2 China Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Type (2020-2025)
6.3.3 China Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Application (2020-2025)
6.3.4 China Paliperidone Palmitate Long-Acting Injection Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Paliperidone Palmitate Long-Acting Injection Sales by Company
6.4.1.1 Japan Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025)
6.4.1.2 Japan Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025)
6.4.2 Japan Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Type (2020-2025)
6.4.3 Japan Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Application (2020-2025)
6.4.4 Japan Paliperidone Palmitate Long-Acting Injection Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Paliperidone Palmitate Long-Acting Injection Sales by Company
6.5.1.1 India Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025)
6.5.1.2 India Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025)
6.5.2 India Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Type (2020-2025)
6.5.3 India Paliperidone Palmitate Long-Acting Injection Sales Breakdown by Application (2020-2025)
6.5.4 India Paliperidone Palmitate Long-Acting Injection Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Janssen Pharmaceuticals
7.1.1 Janssen Pharmaceuticals Company Information
7.1.2 Janssen Pharmaceuticals Business Overview
7.1.3 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Products Offered
7.1.5 Janssen Pharmaceuticals Recent Development
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Information
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Products Offered
7.2.5 Teva Pharmaceutical Recent Development
7.3 Viatris
7.3.1 Viatris Company Information
7.3.2 Viatris Business Overview
7.3.3 Viatris Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Viatris Paliperidone Palmitate Long-Acting Injection Products Offered
7.3.5 Viatris Recent Development
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Information
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Products Offered
7.4.5 Sun Pharmaceutical Recent Development
7.5 Cipla
7.5.1 Cipla Company Information
7.5.2 Cipla Business Overview
7.5.3 Cipla Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Cipla Paliperidone Palmitate Long-Acting Injection Products Offered
7.5.5 Cipla Recent Development
7.6 Hikma Pharmaceuticals
7.6.1 Hikma Pharmaceuticals Company Information
7.6.2 Hikma Pharmaceuticals Business Overview
7.6.3 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Products Offered
7.6.5 Hikma Pharmaceuticals Recent Development
7.7 Qilu Pharmaceutical
7.7.1 Qilu Pharmaceutical Company Information
7.7.2 Qilu Pharmaceutical Business Overview
7.7.3 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Products Offered
7.7.5 Qilu Pharmaceutical Recent Development
7.8 Hansoh Pharmaceuticak Group
7.8.1 Hansoh Pharmaceuticak Group Company Information
7.8.2 Hansoh Pharmaceuticak Group Business Overview
7.8.3 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Products Offered
7.8.5 Hansoh Pharmaceuticak Group Recent Development
7.9 Luye Pharma Group
7.9.1 Luye Pharma Group Company Information
7.9.2 Luye Pharma Group Business Overview
7.9.3 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Products Offered
7.9.5 Luye Pharma Group Recent Development
8 Paliperidone Palmitate Long-Acting Injection Manufacturing Cost Analysis
8.1 Paliperidone Palmitate Long-Acting Injection Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Paliperidone Palmitate Long-Acting Injection
8.4 Paliperidone Palmitate Long-Acting Injection Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Paliperidone Palmitate Long-Acting Injection Distributors List
9.3 Paliperidone Palmitate Long-Acting Injection Customers
10 Paliperidone Palmitate Long-Acting Injection Market Dynamics
10.1 Paliperidone Palmitate Long-Acting Injection Industry Trends
10.2 Paliperidone Palmitate Long-Acting Injection Market Drivers
10.3 Paliperidone Palmitate Long-Acting Injection Market Challenges
10.4 Paliperidone Palmitate Long-Acting Injection Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Paliperidone Palmitate Long-Acting Injection Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Paliperidone Palmitate Long-Acting Injection Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Paliperidone Palmitate Long-Acting Injection Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) by Region (2020-2025)
Table 5. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Region (2020-2025)
Table 6. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Region (2020-2025)
Table 8. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Forecast by Region (2026-2031)
Table 9. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Paliperidone Palmitate Long-Acting Injection Revenue Share Forecast by Region (2026-2031)
Table 12. Global Paliperidone Palmitate Long-Acting Injection Sales by Type (K Dose) & (2020-2025)
Table 13. Global Paliperidone Palmitate Long-Acting Injection Sales Share by Type (2020-2025)
Table 14. Global Paliperidone Palmitate Long-Acting Injection Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Paliperidone Palmitate Long-Acting Injection Price by Type (US$/Dose) & (2020-2025)
Table 16. Global Paliperidone Palmitate Long-Acting Injection Sales by Type (K Dose) & (2026-2031)
Table 17. Global Paliperidone Palmitate Long-Acting Injection Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Paliperidone Palmitate Long-Acting Injection Price by Type (US$/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Paliperidone Palmitate Long-Acting Injection Sales by Application (K Dose) & (2020-2025)
Table 21. Global Paliperidone Palmitate Long-Acting Injection Sales Share by Application (2020-2025)
Table 22. Global Paliperidone Palmitate Long-Acting Injection Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Paliperidone Palmitate Long-Acting Injection Price by Application (US$/Dose) & (2020-2025)
Table 24. Global Paliperidone Palmitate Long-Acting Injection Sales by Application (K Dose) & (2026-2031)
Table 25. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Paliperidone Palmitate Long-Acting Injection Price by Application (US$/Dose) & (2026-2031)
Table 27. New Sources of Growth in Paliperidone Palmitate Long-Acting Injection Application
Table 28. Global Paliperidone Palmitate Long-Acting Injection Sales by Company (K Dose) & (2020-2025)
Table 29. Global Paliperidone Palmitate Long-Acting Injection Sales Share by Company (2020-2025)
Table 30. Global Paliperidone Palmitate Long-Acting Injection Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Company (2020-2025)
Table 32. Global Paliperidone Palmitate Long-Acting Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone Palmitate Long-Acting Injection as of 2024)
Table 33. Global Market Paliperidone Palmitate Long-Acting Injection Average Price by Company (US$/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Product Type & Application
Table 36. Global Key Manufacturers of Paliperidone Palmitate Long-Acting Injection, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025) & (K Dose)
Table 39. North America Paliperidone Palmitate Long-Acting Injection Sales Market Share by Company (2020-2025)
Table 40. North America Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2020-2025)
Table 42. North America Paliperidone Palmitate Long-Acting Injection Sales by Type (2020-2025) & (K Dose)
Table 43. North America Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2020-2025)
Table 44. North America Paliperidone Palmitate Long-Acting Injection Sales by Application (2020-2025) & (K Dose)
Table 45. North America Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2020-2025)
Table 46. Europe Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025) & (K Dose)
Table 47. Europe Paliperidone Palmitate Long-Acting Injection Sales Market Share by Company (2020-2025)
Table 48. Europe Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2020-2025)
Table 50. Europe Paliperidone Palmitate Long-Acting Injection Sales by Type (2020-2025) & (K Dose)
Table 51. Europe Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2020-2025)
Table 52. Europe Paliperidone Palmitate Long-Acting Injection Sales by Application (2020-2025) & (K Dose)
Table 53. Europe Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2020-2025)
Table 54. China Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025) & (K Dose)
Table 55. China Paliperidone Palmitate Long-Acting Injection Sales Market Share by Company (2020-2025)
Table 56. China Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2020-2025)
Table 58. China Paliperidone Palmitate Long-Acting Injection Sales by Type (2020-2025) & (K Dose)
Table 59. China Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2020-2025)
Table 60. China Paliperidone Palmitate Long-Acting Injection Sales by Application (2020-2025) & (K Dose)
Table 61. China Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2020-2025)
Table 62. Japan Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025) & (K Dose)
Table 63. Japan Paliperidone Palmitate Long-Acting Injection Sales Market Share by Company (2020-2025)
Table 64. Japan Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2020-2025)
Table 66. Japan Paliperidone Palmitate Long-Acting Injection Sales by Type (2020-2025) & (K Dose)
Table 67. Japan Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2020-2025)
Table 68. Japan Paliperidone Palmitate Long-Acting Injection Sales by Application (2020-2025) & (K Dose)
Table 69. Japan Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2020-2025)
Table 70. India Paliperidone Palmitate Long-Acting Injection Sales by Company (2020-2025) & (K Dose)
Table 71. India Paliperidone Palmitate Long-Acting Injection Sales Market Share by Company (2020-2025)
Table 72. India Paliperidone Palmitate Long-Acting Injection Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Company (2020-2025)
Table 74. India Paliperidone Palmitate Long-Acting Injection Sales by Type (2020-2025) & (K Dose)
Table 75. India Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type (2020-2025)
Table 76. India Paliperidone Palmitate Long-Acting Injection Sales by Application (2020-2025) & (K Dose)
Table 77. India Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application (2020-2025)
Table 78. Janssen Pharmaceuticals Company Information
Table 79. Janssen Pharmaceuticals Description and Business Overview
Table 80. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 81. Janssen Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product
Table 82. Janssen Pharmaceuticals Recent Development
Table 83. Teva Pharmaceutical Company Information
Table 84. Teva Pharmaceutical Description and Business Overview
Table 85. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 86. Teva Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product
Table 87. Teva Pharmaceutical Recent Development
Table 88. Viatris Company Information
Table 89. Viatris Description and Business Overview
Table 90. Viatris Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 91. Viatris Paliperidone Palmitate Long-Acting Injection Product
Table 92. Viatris Recent Development
Table 93. Sun Pharmaceutical Company Information
Table 94. Sun Pharmaceutical Description and Business Overview
Table 95. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 96. Sun Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product
Table 97. Sun Pharmaceutical Recent Development
Table 98. Cipla Company Information
Table 99. Cipla Description and Business Overview
Table 100. Cipla Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 101. Cipla Paliperidone Palmitate Long-Acting Injection Product
Table 102. Cipla Recent Development
Table 103. Hikma Pharmaceuticals Company Information
Table 104. Hikma Pharmaceuticals Description and Business Overview
Table 105. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 106. Hikma Pharmaceuticals Paliperidone Palmitate Long-Acting Injection Product
Table 107. Hikma Pharmaceuticals Recent Development
Table 108. Qilu Pharmaceutical Company Information
Table 109. Qilu Pharmaceutical Description and Business Overview
Table 110. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 111. Qilu Pharmaceutical Paliperidone Palmitate Long-Acting Injection Product
Table 112. Qilu Pharmaceutical Recent Development
Table 113. Hansoh Pharmaceuticak Group Company Information
Table 114. Hansoh Pharmaceuticak Group Description and Business Overview
Table 115. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 116. Hansoh Pharmaceuticak Group Paliperidone Palmitate Long-Acting Injection Product
Table 117. Hansoh Pharmaceuticak Group Recent Development
Table 118. Luye Pharma Group Company Information
Table 119. Luye Pharma Group Description and Business Overview
Table 120. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 121. Luye Pharma Group Paliperidone Palmitate Long-Acting Injection Product
Table 122. Luye Pharma Group Recent Development
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Paliperidone Palmitate Long-Acting Injection Distributors List
Table 126. Paliperidone Palmitate Long-Acting Injection Customers List
Table 127. Paliperidone Palmitate Long-Acting Injection Market Trends
Table 128. Paliperidone Palmitate Long-Acting Injection Market Drivers
Table 129. Paliperidone Palmitate Long-Acting Injection Market Challenges
Table 130. Paliperidone Palmitate Long-Acting Injection Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Paliperidone Palmitate Long-Acting Injection Product Picture
Figure 2. Global Paliperidone Palmitate Long-Acting Injection Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Type in 2024 & 2031
Figure 4. Monthly Dosage Form Product Picture
Figure 5. Quarterly Dosage Form Product Picture
Figure 6. Global Paliperidone Palmitate Long-Acting Injection Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Paliperidone Palmitate Long-Acting Injection Sales Market Share by Application in 2024 & 2031
Figure 8. General Hospital Examples
Figure 9. Specialized Hospital Examples
Figure 10. Others Examples
Figure 11. Global Paliperidone Palmitate Long-Acting Injection Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Paliperidone Palmitate Long-Acting Injection Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Growth Rate (2020-2031)
Figure 14. Global Paliperidone Palmitate Long-Acting Injection Price Trends Growth Rate (2020-2031) & (US$/Dose)
Figure 15. Paliperidone Palmitate Long-Acting Injection Report Years Considered
Figure 16. Global Market Paliperidone Palmitate Long-Acting Injection Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Paliperidone Palmitate Long-Acting Injection Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Growth Rate (2020-2031)
Figure 20. Europe Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Growth Rate (2020-2031)
Figure 22. China Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Growth Rate (2020-2031)
Figure 24. Japan Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Growth Rate (2020-2031)
Figure 26. India Paliperidone Palmitate Long-Acting Injection Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. India Paliperidone Palmitate Long-Acting Injection Sales (K Dose) Growth Rate (2020-2031)
Figure 28. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Type (2020-2025)
Figure 29. Global Paliperidone Palmitate Long-Acting Injection Sales Share by Type (2026-2031)
Figure 30. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Type (2026-2031)
Figure 31. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Application (2020-2025)
Figure 32. Global Paliperidone Palmitate Long-Acting Injection Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Paliperidone Palmitate Long-Acting Injection Sales Share by Application (2026-2031)
Figure 34. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Application (2026-2031)
Figure 35. Global Paliperidone Palmitate Long-Acting Injection Sales Share by Company (2024)
Figure 36. Global Paliperidone Palmitate Long-Acting Injection Revenue Share by Company (2024)
Figure 37. Global 5 Largest Paliperidone Palmitate Long-Acting Injection Players Market Share by Revenue in Paliperidone Palmitate Long-Acting Injection: 2020 & 2024
Figure 38. Paliperidone Palmitate Long-Acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Paliperidone Palmitate Long-Acting Injection
Figure 40. Manufacturing Process Analysis of Paliperidone Palmitate Long-Acting Injection
Figure 41. Paliperidone Palmitate Long-Acting Injection Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Related Reports
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 141
USD 4900.00
(Single User License)
Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-04-25
Pages: 95
USD 3950.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-04-25
Pages: 83
USD 2900.00
(Single User License)
Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 99
USD 3950.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 80
USD 4250.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 110
USD 2900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 147
USD 4900.00
(Single User License)
Global Paliperidone Palmitate Long-Acting Injection Market Insights, Forecast to 2031
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6283 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 141
USD 4900.00 (Single User License)Paliperidone Palmitate Long-Acting Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4115 million in 2024 and is forecast to a readjusted size of US$ 6283 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-04-25
Pages: 95
USD 3950.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2025
The global market for Paliperidone Palmitate Long-Acting Injection was valued at US$ 4115 million in the year 2024 and is projected to reach a revised size of US$ 6283 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-04-25
Pages: 83
USD 2900.00 (Single User License)Paliperidone Palmitate Long-Acting Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paliperidone Palmitate Long-Acting Injection was estimated to be worth US$ 4355 million in 2025 and is projected to reach US$ 6640 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 99
USD 3950.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Paliperidone Palmitate Long-Acting Injection market size was US$ 4355 million in 2025 and is forecast to reach a readjusted size of US$ 6640 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 80
USD 4250.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Research Report 2026
The global Paliperidone Palmitate Long-Acting Injection market was valued at US$ 4355 million in 2025 and is anticipated to reach US$ 6640 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-03-11
Pages: 110
USD 2900.00 (Single User License)Global Paliperidone Palmitate Long-Acting Injection Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Paliperidone Palmitate Long-Acting Injection market is projected to grow from US$ 4355 million in 2025 to US$ 6640 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 147
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research